Regulation of Cardiomyocyte Turnover in the Adult Mammalian Heart
成年哺乳动物心脏心肌细胞周转的调节
基本信息
- 批准号:9240660
- 负责人:
- 金额:$ 40.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAdultAge-YearsAgingBiologyBirthCardiacCardiac MyocytesCardiovascular systemCell CycleCell Cycle ArrestCell SizeCharacteristicsChestChimeric ProteinsCompetenceDNA DamageDataExposure toGeneticGoalsHeartHeart failureHomeostasisHumanHypoxiaInjuryIonizing radiationLasersLongevityMaintenanceMapsMeasurableMediatingMediator of activation proteinMessenger RNAMicrodissectionMitochondriaModelingMuscle CellsNamesNatureNeonatalOxygenPathologyPopulationProcollagen-Proline DioxygenaseProteinsRadiation Induced DNA DamageReactive Oxygen SpeciesRegulationRoleSecondary toSignal TransductionTamoxifenTherapeuticTimeTransforming Growth Factor betaTransgenic MiceUp-Regulationbiological adaptation to stresscardiac regenerationinsightmouse modeloxidative DNA damagepostnatalpromoterpublic health relevanceregenerativeresponsetooltranscriptome sequencingtreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Regulation of mammalian cardiomyocyte cell cycle has been a central question in cardiovascular biology for decades, secondary to the burden of heart failure. Although the adult heart does not have a significant regenerative potential, it has recently become clear that measurable cardiomyocyte turnover does in fact occur in the adult heart, mediated by proliferation of pre-existing cardiomyocytes. In fact, the rate of cardiomyocyte turnover in the adult human heart is about 2% per year between 20 and 40 years of age, and 0.5 -1% per year thereafter. While this rate of myocyte turnover is insufficient for heart regeneration following injury, it is critical for constant replacement of dead or damaged myocytes. As a result, close to 45% of cardiomyocytes in a human heart are replaced throughout its lifespan. We recently showed that an important mechanism of cell cycle arrest of the majority of cardiomyocytes postnatally is mitochondrial reactive oxygen species (ROS)-mediated oxidative DNA damage, and activation of DNA damage response (DDR). Moreover, we developed the first mouse model to fate map the rare population of cycling cardiomyocytes in the postnatal heart, and we found that these cycling cardiomyocytes are characterized by upregulation of hypoxic stress response and are protected from the oxidative DNA damage. Therefore, we propose to examine the mechanism of cardiomyocyte turnover in the adult mammalian heart using the fate-mapping model that we developed. We will first characterize the dynamics of hypoxic cardiomyocyte turnover in the neonatal, adult and ageing heart. We will also examine the role of DNA damage in regulation of hypoxic cardiomyocyte turnover. Finally, we will investigate the endogenous mechanism of maintenance of hypoxia signaling in cycling cardiomyocytes. Achieving the goals of this proposal will provide new insights into the mechanism of cardiomyocyte turnover in the adult mammalian heart. We hope to exploit these results to develop new strategies to enhance cardiomyocyte renewal in the failing heart.
描述(由申请人提供):几十年来,哺乳动物心肌细胞周期的调节一直是心血管生物学的中心问题,仅次于心力衰竭的负担。尽管成人心脏没有明显的再生潜力,但最近发现,在成人心脏中确实发生了可测量的心肌细胞周转,这是由先前存在的心肌细胞的增殖介导的。事实上,成人心脏的心肌细胞周转率在20-40岁之间每年约为2%,此后每年约为0.5%-1%。虽然这种心肌细胞周转率不足以使损伤后的心脏再生,但对于死亡或受损的心肌细胞的持续更新是至关重要的。结果,人类心脏中近45%的心肌细胞在整个生命周期内被替换。我们最近发现,线粒体活性氧(ROS)介导的DNA氧化损伤和DNA损伤反应(DDR)的激活是大多数生后心肌细胞细胞周期停滞的重要机制。此外,我们建立了第一个小鼠模型来定位出生后心脏中罕见的循环心肌细胞群,我们发现这些循环心肌细胞的特征是低氧应激反应上调,并受到氧化DNA损伤的保护。因此,我们建议使用我们开发的命运映射模型来研究成年哺乳动物心脏中心肌细胞周转的机制。我们将首先描述缺氧心肌细胞在新生儿、成人和衰老心脏中的周转动力学。我们还将研究DNA损伤在低氧心肌细胞周转调节中的作用。最后,我们将探讨循环心肌细胞维持低氧信号的内源性机制。实现这一建议的目标将为成年哺乳动物心脏中心肌细胞周转的机制提供新的见解。我们希望利用这些结果来开发新的策略来加强衰竭心脏的心肌细胞更新。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hesham Sadek其他文献
Hesham Sadek的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hesham Sadek', 18)}}的其他基金
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
免疫反应介导的心肌细胞生长和更新调节
- 批准号:
10625948 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte Proliferation
供需:氧气和工作量调节心肌细胞增殖
- 批准号:
10572541 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Role of cGAS-STING in cardiomyocyte cell cycle regulation
cGAS-STING 在心肌细胞周期调节中的作用
- 批准号:
10625952 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Project 3 - Role of Proline Metabolism in Regulation of Mammalian Cardiomyocyte Proliferation
项目3 - 脯氨酸代谢在哺乳动物心肌细胞增殖调节中的作用
- 批准号:
10493840 - 财政年份:2022
- 资助金额:
$ 40.5万 - 项目类别:
Project 3 - Role of Proline Metabolism in Regulation of Mammalian Cardiomyocyte Proliferation
项目3 - 脯氨酸代谢在哺乳动物心肌细胞增殖调节中的作用
- 批准号:
10677735 - 财政年份:2022
- 资助金额:
$ 40.5万 - 项目类别:
Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals
破译大型动物的新生儿心脏再生潜力和调节器
- 批准号:
10207761 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Calcineurin Regulates Cardiomyocyte Cell Cycle Through Meis1 and Hoxb13
钙调神经磷酸酶通过 Meis1 和 Hoxb13 调节心肌细胞周期
- 批准号:
10371869 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals
破译大型动物的新生儿心脏再生潜力和调节器
- 批准号:
10442732 - 财政年份:2019
- 资助金额:
$ 40.5万 - 项目类别:
Regulation of Cardiomyocyte Turnover in the Adult Mammalian Heart
成年哺乳动物心脏心肌细胞周转的调节
- 批准号:
9463489 - 财政年份:2016
- 资助金额:
$ 40.5万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 40.5万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 40.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)